Showing 1191-1200 of 4307 results for "".
Radiesse for Hands, Alevicyn Cleared
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-radiesse-for-hands-alevicyn-cleared/18898/Merz gets FDA approval for Radiesse for hand augmentation and releases data comparing Xeomin to Botox. Heidi Waldorf, MD, FAAD and Michael Gold, MD, FAAD, comment. Also in this edition, Galderma participate in a White House forum on antibiotic stewardship, and the FDA gives 510(k) clearance to AleviFacebook Graph Search-An Important Marketing Tool for Doctors
https://practicaldermatology.com/topics/practice-management/facebook-graph-search-an-important-marketing-tool-for-doctors/18931/Graph searching is the latest tool offered by Facebook. Here's what it is and how you can use it in your practice. An Ekwa Marketing Educational video.Dos and don'ts for creating a killer Google Adwords Campaign for your Dermatology Practice
https://practicaldermatology.com/topics/practice-management/dos-and-don-ts-for-creating-a-killer-google-adwords-campaign-for-your-dermatology-practice/18907/Google AdWords could be a great way to promote your practice. But you have to do it right! Learn how to plan and implement a campaign that gets results with reasonable costs.The State of Dermatology Entrepreneurship 2015
https://practicaldermatology.com/topics/practice-management/the-state-of-dermatology-entrepreneurship-2015/18913/William Ju, MD, President of Advancing Innovation in Dermatology talks about entrepreneurship in dermatology. Where are new ideas, technologies, and therapies coming from, and how will they move ahead? Dr. Ju talks about the role of the pharmaceutical industry and finding resources.Kythera's Kybella Approved; ASLMS Update
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-kythera-s-kybella-approved-aslms-update/18925/FDA Approves Kythera's Kybella (ATX-101 or deoxycholic acid) injection for reduction of sub mental fullness or double chin. ASLMS Recognizes women in device-based medicine (Women in Energy-based Devices). Deka and Syneron get new clearances. ASDS Launches Skin Cancer PSAs, and Foamix sells shares.The Importance of Skincare
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-importance-of-skincare/19035/Whether patients want lasers, injectables, Botox, or cosmeceuticals, they need guidance on proper skincare to prevent wrinkles and skin cancer, says Dina Anderson, MD, FAAD. Patients need to learn about antioxidants, free radicals, and the effects of smoking.SEO Playbook: On-Page Factors
https://practicaldermatology.com/topics/practice-management/seo-playbook-on-page-factors/18994/Internet marketing is constantly changing--especially when it comes to SEO. Learn how on-page factors like Content, HTML, and architecture affect SEO and the marketing value of your practice website.Google Maps: It's More Important Than You Think
https://practicaldermatology.com/topics/practice-management/google-maps-it-s-more-important-than-you-think/18997/An Ekwa Marketing education video (Ekwa.com). Google map results are important to provide your practice a page one listing for Google search results and provides a way for patients to find you easily. Google Map listings improve your SEO, too!Injectable Pearl: Microcannulas
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/injectable-pearl-microcannulas/19087/The microcannula is changing the art of aesthetic injectables but it's not right in very situation. Key to success is knowing when to use the cannula versus a needle, says Julius Few, MD.DermwireTV — Valeant Ups Allergan Bid, Nestle Buys Injectables, and Allergan Makes Its Case
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-valeant-ups-allergan-bid-nestle-buys-injectables-and-allergan-makes-its-case/19128/BREAKING NEWS: Valeant has increased its offer for Allergan to $72 per share. Read more. Valeant sells the rights to its aesthetic injectables to Nestle, while Allergan touts physician support and challenges Valeant's business model. In this week's edition of DermWireTV, learn about Valeant's lates